
Vikas Lifecare Limited Announces Results for Q&FY Q1 and Q&FY Q2 of FY 2025-26
Vikas Lifecare Limited announced the results for the quarter and nine months ended December 31, 2025, following the Board meeting held on April 21, 2026. The company also provided detailed standalone and consolidated financial results for the quarter and half year ended September 30, 2025.The board approved the un-audited financial results for the nine months ended December 31, 2025, and the quarter and half year ended September 30, 2025, following limited review by the Statutory Auditors.
Financial Performance Summary
The company's financial results show the following key figures:| Particulars | Three Months Ended December 31, 2025 | Three Months Ended September 30, 2025 | Three Months Ended December 31, 2024 | Nine Months Ended December 31, 2025 | Year Ended March 31, 2025 |
|---|---|---|---|---|---|
| Total Income | 9,775.81 | 14,219.10 | 11,712.49 | 46,560.00 | 48,990.27 |
| Total Expenses | 11,615.69 | 14,829.44 | 12,286.48 | 36,224.15 | 51,293.57 |
| Net Profit/(Loss) for the Period | (2,927.64) | (11,896.04) | (685.69) | (365.09) | (225.66) |
| Total Comprehensive Income (Loss) | (35.47) | (692.72) | (2,302.96) | (1,061.39) | (151.69) |
Note: Figures are presented in Lakhs.
The total income for the quarter and nine months ended December 31, 2025, was 9,775.81 Lakhs for the three months ended, and 46,560.00 Lakhs for the nine months ended. The total expenses for the same period were 11,615.69 Lakhs and 36,224.15 Lakhs, respectively.
Significant Business Transactions
The company provided detailed information regarding two major transactions influencing its results:1. Ebix International Holdings Limited (EIHL) Settlement:
The company reported necessary adjustments related to the settlement of a transaction involving Ebix International Holdings Limited (EIHL). Vikas Lifecare Limited (VLL) had previously contributed ₹ 2,977.27 million (equivalent to US$ 34.83 million) towards the acquisition of Ebix Inc. through a consortium led by Eraaya Lifespaces Limited (ELL). Due to non-repayment by ELL, VLL invoked the arbitration clause, leading to a settlement deed finalized during the quarter ended June 30, 2025. Consequently, 51% of equity shares of EIHL were transferred to VLL, necessitating restatements to the unaudited financial results for the quarter ended June 30, 2025. The company noted that the management is coordinating with legal and regulatory advisors to regularize compliance for this cross-border transaction.
2. Investment in IGL Genesis Technologies Limited (IGTL):
A Share Purchase Agreement was executed by Genesis Gas Solutions Private Limited (GGPL) with VLL for the transfer of its investment in IGTL. While the shares were transferred in dematerialized form in May 2025, the transfer remains pending due to requisite approvals from the Boards of Indraprastha Gas Limited (IGL) and IGTL. Accordingly, the accounting treatment of the investment has not been given effect in the books of account, and the final determination is subject to receiving necessary approvals.
Accounting Changes and Disclosures
The unaudited consolidated financial results for the quarter and nine months ended December 31, 2025, have been reviewed by the auditors. These results reflect restated figures for the quarter and half year ended June 30, 2025, incorporating the adjustment related to the Ebix International Holdings Ltd.The company's segment operations are divided into the following operating segments:
- Trading & Manufacturing Division - Agro
- Trading & Manufacturing Division -Polymers
- Trading & Manufacturing Division -Infrastructure
- Trading Division- Gas Meter
For the quarter ended December 31, 2025, the revenue generated across segments stood at 9,702.93 Lakhs. The company indicated that for the nine months ended December 31, 2025, it does not have major customers as per IND-AS 108, though the Agro segment accounted for a significant portion of the total revenue.
Investment Status and Compliance
The company’s financial statements reflect that the Investment in Unquoted shares/securities are subject to fair valuation and have been kept at book value. Regarding related party transactions, the company noted that shareholder approval for material related party transactions is still pending, and management is in the process of evaluating necessary regulatory compliance.The company’s overall asset portfolio stands at 73,128.45 in the consolidated balance sheet as at September 30, 2025, compared to 72,926.00 on March 31, 2025. Total equity was 55,396.12 Lakhs, and total liabilities reached 17,732.34 Lakhs.
VIKASLIFE Stock Price Movement
On Tuesday, Vikas Lifecare Limited shares rallied, settling at ₹1.65 after gaining 0.61% on the previous session. The stock saw significant trading activity, with 1.58 million shares transacting during the day.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.